¹û¶³Ó°Ôº

XClose

¹û¶³Ó°Ôº News

Home
Menu

Screening can pick up early signs of womb cancer

13 December 2010

Links:

Professor Ian Jacobs instituteforwomenshealth.ucl.ac.uk/womens-cancer/gcrc" target="_self">¹û¶³Ó°Ôº Gynaecological Cancer Research Centre
  • In a paper published today in Lancet Oncology, scientists in the Gynaecological Cancer Research Centre at ¹û¶³Ó°Ôº have demonstrated that an ultrasound scanÌýbeing used in screening trials for ovarian cancer can also pick up Ìýsigns of endometrial cancer before any symptoms occur.

    This is the first large scale study of screening for endometrial (womb) cancer, which is increasing in incidence and is responsible for over 1,700 deaths per year in the UK.

    The results were achieved using ultrasound scanning to identify thickening of the womb lining (endometrium). Analysis of findings from more than 37,000 women showed that the scans identified a significant difference in womb lining thickness inÌýthe 133Ìýwomen who were diagnosed with womb cancer, or withÌýAtypical Endometrial HyperplasiaÌý(AEH) (which isÌýa precursor of the cancer).ÌýÌýThe average endometrial thickness for these 133 women wasÌý11.5mm whereas for women not diagnosed with either condition the average thickness was 3.5mm.

    25% of the population were identified asÌýbeingÌýat highÌýriskÌýbased on the basis of factors associated with endometrial cancerÌýand included nearly 40% of the cases of endometrial cancer and AEH. This high risk group could be the focus ofÌýa screening programme forÌýwombÌýcancer were it to be implemented and would limitÌýthe burden of diagnostic procedures, false positives and cost.

    The scans were undertaken as part of theÌýUKÌýCollaborative Trial forÌýOvarianÌýCancerÌýScreeningÌý(UKCTOCS)Ìýwhich aims to establish the impact of ovarian cancer screening on ovarian cancer mortality. ÌýUKCTOCS is the world's largest collaborative screening trial,Ìýinvolves more than 200,000 UK womenÌýand reports in 2015.

    The UKCTOCS trial has been funded by the Medical Research Council, Cancer Research UK and the National Institute for Health Research and is supported by gynaecological cancer research charity The Eve Appeal.

    Womb cancer recently overtook ovarian cancer as the most common gynaecological cancer in the UK with more than 7,500 cases diagnosed every year.

    Survival rates for womb cancer are however much better than those for ovarian cancer, and signs and symptoms much easier to spot.

    Professor Ian Jacobs, Head of the research team and Dean of Biomedicine at ¹û¶³Ó°Ôº, said: "Endometrial Cancer has been regarded as a good prognosis cancer but it is increasing in incidence and tragically over 25% of patients still die from the cancer.ÌýThis study shows that it is possible to detect the cancer before any symptoms occur using ultrasound screening and raises the possibility of screening for endometrial cancer as a serious issue.

    "There are of course complex and challenging issues around balancing the cost, positive health impact and unwanted consequences of screening which require careful study and analysis. Nevertheless, I am delighted that the results of this study are encouraging and provide the basis for further important research. In the meantime we encourage women who experience symptoms of abnormal bleeding after the menopause to seek prompt medical advice."


    ¹û¶³Ó°Ôº Context

    The ¹û¶³Ó°Ôº Gynaecological Cancer Research Centre forms part of the ¹û¶³Ó°Ôº Institute for Women's Health. Its overarching goal is to develop methods for risk prediction and early detection of gynaecological cancers. It consists of a clinical research team and a laboratory team supporting clinical trials, and many projects involve cross-school, multidisciplinary collaborations, for example with psychologists working in the various divisions of ¹û¶³Ó°Ôº and ¹û¶³Ó°ÔºH. Current research activity falls into the following main areas: screening, risk assessment for ovarian cancer, biomarker discovery, symptoms in ovarian cancer, and psychosocial studies.Ìý

    Women's health is one of seven areas of initial focus of ¹û¶³Ó°Ôº Partners, ¹û¶³Ó°Ôº's partnership with four of London's biggest and best known hospitals and research centres that has been designated one of the UK's first academic health science centres.

    Related news

    Improving the lives of mothers and children
    Ovarian cancer: ¹û¶³Ó°Ôº screening tests show promising results for early detection